RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $80

Moomoo News07:31 ET · Ratings

RBC Raises Price Target on Edwards Lifesciences to $80 From $75, Keeps Outperform Rating

MT Newswires07:10 ET · Ratings

S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today

Kevin Travers16:12 ET

Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock

Kevin TraversNov 26 10:02 ET

A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Simply Wall StNov 26 10:01 ET

Hold Rating Maintained on Edwards Lifesciences Despite Positive SAPIEN 3 Ultra RESILIA Valve Data

TipRanksNov 25 10:45 ET · Ratings